Cormac G. Kilty

Part of DiaSorin SpA, DiaSorin Ireland Ltd. develops, manufactures, and sells leading diagnostic tests for the identification of diseases and important life science products. The company is based in Blackrock, Ireland. The CEO of the Irish company is Cormac G. Kilty. DiaSorin Ireland was acquired by DiaSorin SpA on July 09, 2008 for $39.20 million.

Oncomark Ltd. Engages in the development and application of biomarker panels. The firm’s products include OncoMasTR and pipeline assays. The company was founded by William M. Gallagher and Steve Carl Penney in 2007 and is headquartered in Belfield, Ireland.

Stonehaven Incubate AG provides investment services in animal health sector. The company is headquartered in Andermatt, Switzerland.

Part of Advanced Medical Solutions Group Plc, Connexicon Medical Ltd. is an Irish company that manufactures and wholesales tissue adhesives and sealants. The company is based in Dublin, Ireland. The company was founded by Padraig Leamy. Padraig Leamy has been the CEO since incorporation. Connexicon Medical was acquired by Advanced Medical Solutions Group Plc on February 01, 2023 for $27.15 million.

The Irish Cancer Society funds various types of cancer research and provides resources such as booklets, leaflets, factsheets, and posters to inform individuals on how to reduce their risk of developing cancer. The location of the Irish Cancer Society is in Ballsbridge, Ireland. Additionally, the organization is examining the financial challenges faced by young cancer patients and their loved ones during treatment.

Part of EKF Diagnostics Holdings Plc, Argutus Medical Ltd. develops and manufactures novel organ injury test and urinary biomarkers for the healthcare industry. The company is based in Dublin, Ireland. The Irish company was founded by Cormac G. Kilty. Argutus Medical was acquired by EKF Diagnostics Holdings Plc on December 02, 2010 for $3.67 million.

Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland.